Remote Monitoring, Cardiac Resynchronization Highlighted At HRS Meeting
This article was originally published in The Gray Sheet
Executive Summary
The role of remote monitoring in detecting significant events earlier in pacemaker patients was a hot topic among the late-breaking clinical trials presented May 15 at the Heart Rhythm Society's annual scientific sessions in San Francisco
You may also be interested in...
Study Shows Promise, But Questions Remain For Cardiac Resynch Expansion
A clinical trial investigating earlier use of cardiac resynchronization therapy (CRT) for patients with milder heart failure symptoms did not meet its primary endpoint, but the investigators say the overall findings should be viewed as positive for the therapy
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.